Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
12/12 | 2,470 USD
-2,76% |
-2,76% |
|
Cabaletta Bio Inc |
15/12 | 2,390 USD
+1,27% |
+1,27% |
|
Calithera Biosciences Inc |
12/12 | 0,000 USD
+200,00% |
+200,00% |
|
Can-Fite Biopharma Ltd |
12/12 | 0,283 USD
-2,18% |
-2,18% |
|
Capricor Therapeutics Inc |
15/12 | 26,550 USD
+2,04% |
+2,04% |
Carbios |
15/12 | 11,970 EUR
+1,01% |
+1,01% |
|
Carisma Therapeutics, Inc. |
15/12 | 0,055 USD
+2,04% |
+2,04% |
|
CASI Pharmaceuticals Inc |
12/12 | 0,863 USD
-7,70% |
-7,70% |
|
Cel-Sci Corp. |
15/12 | 6,000 USD
-5,66% |
-5,66% |
|
Celldex Therapeutics Inc. |
15/12 | 27,090 USD
-1,53% |
-1,53% |
|
Cellectar Biosciences Inc |
15/12 | 3,200 USD
-11,60% |
-11,60% |
|
Cellectis |
12/12 | 4,680 USD
-10,34% |
-10,34% |
|
Cellectis |
15/12 | 4,105 EUR
-0,12% |
-0,12% |
Celyad Oncology |
15/12 | 0,182 EUR
-1,62% |
-1,62% |
|
Champions Oncology Inc |
12/12 | 6,720 USD
+6,67% |
+6,67% |
|
Cidara Therapeutics Inc |
15/12 | 220,100 USD
-0,25% |
-0,25% |
|
Co-Diagnostics Inc |
15/12 | 0,270 USD
-20,88% |
-20,88% |
|
Cogent Biosciences Inc |
12/12 | 42,110 USD
+5,17% |
+5,17% |
|
Coherus Biosciences Inc |
15/12 | 1,390 USD
+2,96% |
+2,96% |
|
CollPlant Biotechnologies Ltd |
12/12 | 1,810 USD
-4,74% |
-4,74% |
|
Compass Pathways Plc |
15/12 | 6,590 USD
-2,23% |
-2,23% |
|
Compugen Ltd. |
15/12 | 1,500 USD
-1,96% |
-1,96% |
|
Corbus Pharmaceuticals Holdings Inc |
12/12 | 9,700 USD
+0,21% |
+0,21% |
|
CRISPR Therapeutics AG |
15/12 | 56,250 USD
-0,76% |
-0,76% |
|
Cue Biopharma Inc |
12/12 | 0,487 USD
-1,24% |
-1,24% |
|
Curis Inc |
15/12 | 1,190 USD
+2,59% |
+2,59% |
|
Cytokinetics Inc |
15/12 | 62,160 USD
-1,88% |
-1,88% |
|
CytomX Therapeutics Inc |
12/12 | 4,190 USD
+3,20% |
+3,20% |